[The results of experimental and clinical studies of a multicomponent vaccine made of the antigens from opportunistic microorganisms].
Egorova
N B
NB
Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
Efremova
V N
VN
Kurbatova
E A
EA
Kuz'mina
L A
LA
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004926:Escherichia coli / Q000276:immunology*; D006801:Humans; D007711:Klebsiella pneumoniae / Q000276:immunology*; D011514:Proteus vulgaris / Q000276:immunology*; D013209:Staphylococcal Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D013211:Staphylococcus aureus / Q000276:immunology*; D017778:Vaccines, Combined
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D013209:Staphylococcal Vaccines; C088865:VP-4 vaccine; D017778:Vaccines, Combined
Itogi éksperimental'nogo i klinicheskogo izucheniia polikomponentnoĭ vaktsiny iz antigenov uslovno patogennykh mikroorganizmov.